With virtual health transforming the entire healthcare landscape, pharma is leveraging digital health tools to improve its processes.
Today’s mostly paper-dependent clinical trials pose fundamental challenges to the pharmaceutical industry. Such trials can be prohibitively expensive, struggle to enroll and retain a sufficient number of participants, and have difficulty maintaining compliance and data reliability. But with the advent of virtual and partially virtual trials using digital tools and devices, we have the opportunity to substantially improve efficiency by deploying the same design principles that make consumer apps so successful.
How close are we to personalizing healthcare? This was the theme of MM&M and Deloitte Digital’s aptly named event, Humanizing the Health Experience, which took place at Deloitte Digital’s downtown NYC offices earlier this month.
Scientists with the Dominantly Inherited Alzheimer Network (DIAN) at the Washington University in St. Louis School of Medicine are undertaking five years of studies of a rare form of early-onset Alzheimer’s disease using a “bring your own device” (BYOD) study model.
The Washington University School of Medicine in Saint Louis has selected Datacubed Health’s mobile platform has been selected to support worldwide studies for those at risk of Dominantly Inherited Alzheimer’s Disease, a rare form of early-onset Alzheimer’s Disease. The Linkt platform enables the collection of real-time data on sleep, diet and other biomarkers using a “bring your own device” (BYOD) study model.
The Washington University School of Medicine in St. Louis is launching a five-year study that will use an mHealth app and connected health platform to monitor people living with Dominantly Inherited Alzheimer’s Disease.
Datacubed Health’s Mobile Platform Selected to Improve Data Quality and Decrease Patient Burden in Five-Year Washington University Study
If used mindfully, the latest advances in technology could create a more comfortable environment in which we can begin to bring in underrepresented populations and reverse the lack of diversity in clinical trials.
Scientists are to use an app to conduct the first crowdsourcing study on the impact of smartphone use on working memory, mental focus and attention.
With the advent of large-scale databases that measure everything from credit-worthiness (a strong predictor of overall health), to individual social networks (a predictor of mental health), to air quality (a predictor of asthma), comprehensive pheno-typing is becoming practical.